Literature DB >> 9847331

Immunization of woodchucks with plasmids expressing woodchuck hepatitis virus (WHV) core antigen and surface antigen suppresses WHV infection.

M Lu1, G Hilken, J Kruppenbacher, T Kemper, R Schirmbeck, J Reimann, M Roggendorf.   

Abstract

DNA vaccination can induce humoral and cellular immune response to viral antigens and confer protection to virus infection. In woodchucks, we tested the protective efficacy of immune response to woodchuck hepatitis core antigen (WHcAg) and surface antigen (WHsAg) of woodchuck hepatitis virus (WHV) elicited by DNA-based vaccination. Plasmids pWHcIm and pWHsIm containing WHV c- or pre-s2/s genes expressed WHcAg and WHsAg in transient transfection assays. Pilot experiments in mice revealed that a single intramuscular injection of 100 microgram of plasmid pWHcIm DNA induced an anti-WHcAg titer over 1:300 that was enhanced by boost injections. However, two injections of 100 microgram of pWHcIm did not induce detectable anti-WHcAg in woodchucks. With an increase in the dose to 1 mg of pWHcIm per injection, transient anti-WHcAg response and WHcAg-specific proliferation of peripheral mononuclear blood cells (PMBCs) appeared in woodchucks after repeated immunizations. Four woodchucks vaccinated with pWHcIm were challenged with 10(4) or 10(5) of the WHV 50% infective dose. They remained negative for markers of WHV replication (WHV DNA and WHsAg) in peripheral blood and developed anti-WHs in week 5 after challenge. In contrast, woodchucks not immunized or immunized with the control vector pcDNA3 developed acute WHV infection. Two woodchucks immunized with 1 mg of pWHsIm developed WHsAg-specific proliferative response of PBMCs but no measurable anti-WHsAg response. A rapid anti-WHsAg response developed during week 2 after virus challenge. Neither woodchuck developed any signs of WHV infection. These data indicate that DNA-based vaccination with WHcAg and WHsAg can elicit immunity to WHV infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9847331      PMCID: PMC103832     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks.

Authors:  J Summers; J M Smolec; R Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

Review 2.  Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association.

Authors:  W Szmuness
Journal:  Prog Med Virol       Date:  1978

3.  Immunization for Ebola virus infection.

Authors:  L Xu; A Sanchez; Z Yang; S R Zaki; E G Nabel; S T Nichol; G J Nabel
Journal:  Nat Med       Date:  1998-01       Impact factor: 53.440

4.  DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vector.

Authors:  M J Hariharan; D A Driver; K Townsend; D Brumm; J M Polo; B A Belli; D J Catton; D Hsu; D Mittelstaedt; J E McCormack; L Karavodin; T W Dubensky; S M Chang; T A Banks
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

5.  Protective efficacy of DNA vaccines against duck hepatitis B virus infection.

Authors:  M Triyatni; A R Jilbert; M Qiao; D S Miller; C J Burrell
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

6.  DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice.

Authors:  Y L Lin; L K Chen; C L Liao; C T Yeh; S H Ma; J L Chen; Y L Huang; S S Chen; H Y Chiang
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

7.  T-Cell response to woodchuck hepatitis virus (WHV) antigens during acute self-limited WHV infection and convalescence and after viral challenge.

Authors:  S Menne; J Maschke; M Lu; H Grosse-Wilde; M Roggendorf
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

8.  Therapeutic vaccination of woodchucks against chronic woodchuck hepatitis virus infection.

Authors:  S Hervás-Stubbs; J J Lasarte; P Sarobe; J Prieto; J Cullen; M Roggendorf; F Borrás-Cuesta
Journal:  J Hepatol       Date:  1997-10       Impact factor: 25.083

9.  Cytokine and hepatitis B virus DNA co-immunizations enhance cellular and humoral immune responses to the middle but not to the large hepatitis B virus surface antigen in mice.

Authors:  M Geissler; R Schirmbeck; J Reimann; H E Blum; J R Wands
Journal:  Hepatology       Date:  1998-07       Impact factor: 17.425

10.  Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection.

Authors:  M C Jung; H M Diepolder; U Spengler; E A Wierenga; R Zachoval; R M Hoffmann; D Eichenlaub; G Frösner; H Will; G R Pape
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

View more
  24 in total

Review 1.  The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection.

Authors:  Stephan Menne; Paul J Cote
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

Review 2.  The Woodchuck, a Nonprimate Model for Immunopathogenesis and Therapeutic Immunomodulation in Chronic Hepatitis B Virus Infection.

Authors:  Michael Roggendorf; Anna D Kosinska; Jia Liu; Mengji Lu
Journal:  Cold Spring Harb Perspect Med       Date:  2015-10-28       Impact factor: 6.915

3.  X-deficient woodchuck hepatitis virus mutants behave like attenuated viruses and induce protective immunity in vivo.

Authors:  Z Zhang; N Torii; Z Hu; J Jacob; T J Liang
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

4.  CpG oligodeoxynucleotides with hepatitis B surface antigen (HBsAg) for vaccination in HBsAg-transgenic mice.

Authors:  E Malanchère-Brès; P J Payette; M Mancini; P Tiollais; H L Davis; M L Michel
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

5.  Woodchuck gamma interferon upregulates major histocompatibility complex class I transcription but is unable to deplete woodchuck hepatitis virus replication intermediates and RNAs in persistently infected woodchuck primary hepatocytes.

Authors:  Mengji Lu; Beate Lohrengel; Gero Hilken; Thekla Kemper; Michael Roggendorf
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

6.  Novel Woodchuck Hepatitis Virus (WHV) transgene mouse models show sex-dependent WHV replicative activity and development of spontaneous immune responses to WHV proteins.

Authors:  Zhongji Meng; Zhiyong Ma; Ejuan Zhang; Anna D Kosinska; Jia Liu; Xiaoyong Zhang; Tianlun Zhou; Jun Wu; Uta Dahmen; Olaf Dirsch; Dongliang Yang; Michael Roggendorf; Mengji Lu
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

7.  DNA prime-adenovirus boost immunization induces a vigorous and multifunctional T-cell response against hepadnaviral proteins in the mouse and woodchuck model.

Authors:  Anna D Kosinska; Lena Johrden; Ejuan Zhang; Melanie Fiedler; Anja Mayer; Oliver Wildner; Mengji Lu; Michael Roggendorf
Journal:  J Virol       Date:  2012-06-20       Impact factor: 5.103

8.  Bicistronic woodchuck hepatitis virus core and gamma interferon DNA vaccine can protect from hepatitis but does not elicit sterilizing antiviral immunity.

Authors:  Jinguo Wang; Shashi A Gujar; Lucyna Cova; Tomasz I Michalak
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

9.  Combination of an antiviral drug and immunomodulation against hepadnaviral infection in the woodchuck model.

Authors:  Mengji Lu; Xin Yao; Yang Xu; Heike Lorenz; Uta Dahmen; Haidong Chi; Olaf Dirsch; Thekla Kemper; Lifang He; Dieter Glebe; Wolfram H Gerlich; Yumei Wen; Michael Roggendorf
Journal:  J Virol       Date:  2007-12-26       Impact factor: 5.103

10.  Identification of antigenic regions of duck hepatitis B virus core protein with antibodies elicited by DNA immunization and chronic infection.

Authors:  A Thermet; M Robaczewska; C Rollier; O Hantz; C Trepo; G Deleage; L Cova
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.